Literature DB >> 30429591

New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.

Marta Vernero1, Marco Astegiano1, Davide Giuseppe Ribaldone2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30429591     DOI: 10.1038/s41395-018-0422-z

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

Review 1.  The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation.

Authors:  Chiara Amoroso; Federica Perillo; Francesco Strati; Massimo C Fantini; Flavio Caprioli; Federica Facciotti
Journal:  Cells       Date:  2020-05-16       Impact factor: 6.600

2.  Ixekizumab Associated New-Onset Inflammatory Bowel Disease.

Authors:  Amir Nazarian; Andrea Grin; Don Thiwanka Wijeratne
Journal:  ACG Case Rep J       Date:  2020-03-02

Review 3.  Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors.

Authors:  Keira A Fieldhouse; Samantha Ukaibe; Erika L Crowley; Reena Khanna; Ashley O'Toole; Melinda J Gooderham
Journal:  Drugs Context       Date:  2020-04-21

4.  Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.

Authors:  Dagmar Schierova; Radka Roubalova; Martin Kolar; Zuzana Stehlikova; Filip Rob; Zuzana Jackova; Stepan Coufal; Tomas Thon; Martin Mihula; Martin Modrak; Miloslav Kverka; Lukas Bajer; Klara Kostovcikova; Pavel Drastich; Jana Hercogova; Michaela Novakova; Martin Vasatko; Milan Lukas; Helena Tlaskalova-Hogenova; Zuzana Jiraskova Zakostelska
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

Review 5.  Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.

Authors:  Cristina Bezzio; Cristina Della Corte; Marta Vernero; Imma Di Luna; Gianpiero Manes; Simone Saibeni
Journal:  Therap Adv Gastroenterol       Date:  2022-07-28       Impact factor: 4.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.